As of 4:00pm ET
| -0.04 / -0.42%|
The 6 analysts offering 12-month price forecasts for GenMark Diagnostics Inc have a median target of 14.50, with a high estimate of 17.00 and a low estimate of 13.00. The median estimate represents a +52.31% increase from the last price of 9.52.
The current consensus among 7 polled investment analysts is to Buy stock in GenMark Diagnostics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.